These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 381941)

  • 1. A structurally abnormal insulin causing human diabetes.
    Tager H; Given B; Baldwin D; Mako M; Markese J; Rubenstein A; Olefsky J; Kobayashi M; Kolterman O; Poucher R
    Nature; 1979 Sep; 281(5727):122-5. PubMed ID: 381941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three mutant insulins in man.
    Shoelson S; Haneda M; Blix P; Nanjo A; Sanke T; Inouye K; Steiner D; Rubenstein A; Tager H
    Nature; 1983 Apr; 302(5908):540-3. PubMed ID: 6339950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a point mutation in the human insulin gene giving rise to a structurally abnormal insulin (insulin Chicago).
    Kwok SC; Steiner DF; Rubenstein AH; Tager HS
    Diabetes; 1983 Sep; 32(9):872-5. PubMed ID: 6313457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.
    Sakura H; Iwamoto Y; Sakamoto Y; Kuzuya T; Hirata H
    J Clin Invest; 1986 Dec; 78(6):1666-72. PubMed ID: 3537011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
    Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes-associated mutations in insulin identify invariant receptor contacts.
    Xu B; Hu SQ; Chu YC; Wang S; Wang RY; Nakagawa SH; Katsoyannis PG; Weiss MA
    Diabetes; 2004 Jun; 53(6):1599-602. PubMed ID: 15161767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.
    Haneda M; Polonsky KS; Bergenstal RM; Jaspan JB; Shoelson SE; Blix PM; Chan SJ; Kwok SC; Wishner WB; Zeidler A
    N Engl J Med; 1984 May; 310(20):1288-94. PubMed ID: 6371526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene technology, characterization of insulin gene and the relationship to diabetes research.
    Schröder D; Zühlke H
    Endokrinologie; 1982 Jun; 79(2):197-209. PubMed ID: 6751806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic mechanisms of hereditary diabetes mellitus.
    Rüdiger HW; Dreyer M
    Hum Genet; 1983; 63(2):100-6. PubMed ID: 6341209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.
    Nanjo K; Sanke T; Miyano M; Okai K; Sowa R; Kondo M; Nishimura S; Iwo K; Miyamura K; Given BD
    J Clin Invest; 1986 Feb; 77(2):514-9. PubMed ID: 3511099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes in the KK mouse.
    Dulin WE; Wyse BM
    Diabetologia; 1970 Jun; 6(3):317-23. PubMed ID: 4914668
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes mellitus caused by mutations in human insulin: analysis of impaired receptor binding of insulins Wakayama, Los Angeles and Chicago using pharmacoinformatics.
    Islam MA; Bhayye S; Adeniyi AA; Soliman ME; Pillay TS
    J Biomol Struct Dyn; 2017 Mar; 35(4):724-737. PubMed ID: 26950281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
    Pagliara AS; Stillings SN; Haymond MW; Hover BA; Matschinsky FM
    J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective.
    Olefsky JM
    Diabetes; 1981 Feb; 30(2):148-62. PubMed ID: 7009267
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
    Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA
    Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin resistance in diabetes in the obese subject].
    Denard Y; Darnaud J; Barousse C; Navez I
    Journ Annu Diabetol Hotel Dieu; 1984; ():137-49. PubMed ID: 6399530
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of insulin receptors in the pathogenesis and treatment of diabetes].
    Lenti G; Pagano G; Cassader M
    Journ Annu Diabetol Hotel Dieu; 1978; ():73-86. PubMed ID: 349230
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing.
    Yoshimasa Y; Seino S; Whittaker J; Kakehi T; Kosaki A; Kuzuya H; Imura H; Bell GI; Steiner DF
    Science; 1988 May; 240(4853):784-7. PubMed ID: 3283938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.